Oasmia Pharmaceutical: Sales Focus for Oasmia

In an interview published by Nyhetsbyrån Direkt on the 8:th of June, Executive Chairman of the Board Julian Aleksov and Executive Vice President Anders Blom discusses the recently published earnings report and the future prospects of the company. For full story, see http://news.cision.com/cision-promoted/r/sales-focus-for-oasmia,c2025160. For additional information, please contact Executive Vice President Anders Blom, e-mail anders.blom@oasmia.com Tel: +46 18 50 54 40



Documents & Links